Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metformin as an adjuvant in breast cancer treatment
Mohsin H. K. Roshan, Yan K Shing, Nikolai Paul Pace
SAGE Open Medicine (2019) Vol. 7
Open Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

Drugs repurposed: An advanced step towards the treatment of breast cancer and associated challenges
Jonaid Ahmad Malik, Sakeel Ahmed, Bisma Jan, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 145, pp. 112375-112375
Open Access | Times Cited: 73
Metformin Loaded Zein Polymeric Nanoparticles to Augment Antitumor Activity against Ehrlich Carcinoma via Activation of AMPK Pathway: D-Optimal Design Optimization, In Vitro Characterization, and In Vivo Study
Yasmina Elmahboub, Rofida Albash, Mira Magdy William, et al.
Molecules (2024) Vol. 29, Iss. 7, pp. 1614-1614
Open Access | Times Cited: 7
The Use of Metformin to Increase the Human Healthspan
Veronika Piskovatska, Kenneth B. Storey, Alexander Vaiserman, et al.
Advances in experimental medicine and biology (2020), pp. 319-332
Closed Access | Times Cited: 52
Biguanides: Species with versatile therapeutic applications
Deepika Kathuria, Akshay D. Raul, Pravin J. Wanjari, et al.
European Journal of Medicinal Chemistry (2021) Vol. 219, pp. 113378-113378
Closed Access | Times Cited: 49
Mechanisms of cancer cell killing by metformin: a review on different cell death pathways
Xiaoyu Wu, Wenwen Xu, Xiangkun Huan, et al.
Molecular and Cellular Biochemistry (2022) Vol. 478, Iss. 1, pp. 197-214
Closed Access | Times Cited: 31
Research Progress of Metformin in the Treatment of Breast Cancer
雪灵 李
Advances in Clinical Medicine (2025) Vol. 15, Iss. 03, pp. 227-233
Closed Access
Metformin: A Possible Option in Cancer Chemotherapy
Chidiebere V. Ugwueze, Odunze J. Ogamba, Ekenechukwu Young, et al.
Analytical Cellular Pathology (2020) Vol. 2020, pp. 1-10
Open Access | Times Cited: 48
Metformin and long non-coding RNAs in breast cancer
Morteza Gholami, Zeynab Nickhah Klashami, Pirooz Ebrahimi, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 12
Effects of Radiotherapy in Coronary Artery Disease
Rose Mary Ferreira Lisboa da Silva
Current Atherosclerosis Reports (2019) Vol. 21, Iss. 12
Closed Access | Times Cited: 35
Inflammatory Biomarkers and Breast Cancer Risk: A Systematic Review of the Evidence and Future Potential for Intervention Research
Rebecca D. Kehm, Jasmine A. McDonald, Suzanne E. Fenton, et al.
International Journal of Environmental Research and Public Health (2020) Vol. 17, Iss. 15, pp. 5445-5445
Open Access | Times Cited: 32
Natural Products Targeting Cancer Stem Cells for Augmenting Cancer Therapeutics
Ari Meerson, Soliman Khatib, Jamal Mahajna
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 13044-13044
Open Access | Times Cited: 27
Association of metformin, aspirin, and cancer incidence with mortality risk in adults with diabetes
Suzanne G. Orchard, Jessica E. Lockery, Jonathan Broder, et al.
JNCI Cancer Spectrum (2023) Vol. 7, Iss. 2
Open Access | Times Cited: 10
MALAT1-dependent hsa_circ_0076611 regulates translation rate in triple-negative breast cancer
Chiara Turco, Gabriella Esposito, Alessia Iaiza, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 17
Insulin-like growth factor binding protein 5: Diverse roles in cancer
Jennifer A. Waters, Ixchel Urbano, Mikella Robinson, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 16
The prognostic outcome of ‘type 2 diabetes mellitus and breast cancer’ association pivots on hypoxia-hyperglycemia axis
Ilhaam Ayaz Durrani, Attya Bhatti, Peter John
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 22
Metformin Attenuates Bone Cancer Pain by Reducing TRPV1 and ASIC3 Expression
He-Ya Qian, Fang Zhou, Rui Wu, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 21
Common Multiple Primary Cancers Associated With Breast and Gynecologic Cancers and Their Risk Factors, Pathogenesis, Treatment and Prognosis: A Review
Shuwen Ge, Bo Wang, Zihao Wang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 13
Metformin: A Promising Antidiabetic Medication for Cancer Treatment
Wei Mu, Yunyun Jiang, Guoqiang Liang, et al.
Current Drug Targets (2022) Vol. 24, Iss. 1, pp. 41-54
Closed Access | Times Cited: 12
Mini Review: Opposing Pathologies in Cancer and Alzheimer's Disease: Does the PI3K/Akt Pathway Provide Clues?
Rachel Barker, Jeff M.P. Holly, Kalina Biernacka, et al.
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 19
Metformin and survival of women with breast cancer: A meta‐analysis of randomized controlled trials
Qiandan Wang, Xiufen Ma, Jianping Long, et al.
Journal of Clinical Pharmacy and Therapeutics (2021) Vol. 47, Iss. 3, pp. 263-269
Open Access | Times Cited: 17
Effects of metformin on adipose-derived stromal cell (ADSC) – Breast cancer cell lines interaction
Maryana Teufelsbauer, Barbara H. Rath, Adelina Plangger, et al.
Life Sciences (2020) Vol. 261, pp. 118371-118371
Closed Access | Times Cited: 17
Predictive value of exosomes and their cargo in drug response/resistance of breast cancer patients
Heidi Schwarzenbach, Peter B. Gahan
Cancer Drug Resistance (2020)
Open Access | Times Cited: 16
Normalizing glucose levels reconfigures the mammary tumor immune and metabolic microenvironment and decreases metastatic seeding
Heba Allah Alsheikh, Brandon J. Metge, Chae‐Myeong Ha, et al.
Cancer Letters (2021) Vol. 517, pp. 24-34
Open Access | Times Cited: 14
A New and Integral Approach to the Etiopathogenesis and Treatment of Breast Cancer Based upon Its Hydrogen Ion Dynamics
Salvador Harguindey, Khalid O. Alfarouk, Julián Polo Orozco, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 3, pp. 1110-1110
Open Access | Times Cited: 15
The crosstalk within the breast tumor microenvironment in type II diabetes: Implications for cancer disparities
Christina S. Ennis, Pablo Llevenes, Yuhan Qiu, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top